Atrial fibrillation (AF) is the most common form of arrhythmia, which can go unnoticed for a long time, but significantly increases the risk of stroke. Interestingly, men and women experience this disease differently. That is why modern diagnostics must take these differences into account - and this is where the Swiss brand Microlife comes to the rescue.
Why are men more likely to have AF?
According to statistics, men are about 1.5 times more likely to develop AF. They are also more likely to experience typical symptoms: palpitations, chest pain, shortness of breath. This is what makes them seek help earlier.
Women are more likely to be under-screened
AF in women is detected later, as it is often masked by nonspecific symptoms: fatigue, dizziness, anxiety. Such "silence" of the disease complicates timely diagnosis, which increases the risks, including stroke.
In addition, women live longer on average, so among people aged 75+, they are more likely to have AF. In such cases, diagnosis is even more important, because with age, the number of concomitant factors increases - hypertension, diabetes, vascular problems.
Why are strokes more common in women?
Even though AF does not always cause noticeable symptoms, the risk of stroke is real—and it is higher in women. According to research, women with AF have a 50% higher risk of ischemic stroke than men. This is due to both biological and social factors: late detection, less aggressive treatment, hormonal changes after menopause.
Fewer procedures, more symptoms
Although women are more likely to complain of unpleasant symptoms of AF, they are less likely to receive invasive treatment (catheter ablation, cardioversion). This is sometimes explained by age or vulnerability, but in reality it can reduce the chances of effective recovery.
How does Microlife help detect AF at an early stage?
Unlike conventional blood pressure monitors, Microlife models with AFIB technology can detect possible atrial fibrillation during routine home blood pressure measurements. This is especially important for women who may not experience classic symptoms.